We’re thrilled to share major milestones as we push forward into commercialization!
Official U.S. Launch
The Turbo® O₂ Cap officially launched in the United States on March 11, 2025—a groundbreaking step for this first-of-its-kind medical device!
Expanding Sales Efforts
- Hospital Partnerships – We’re actively building an Independent Sales Representative force to introduce the Turbo® O₂ Cap into civilian hospitals across the U.S.
- Military & VA Integration – We’re working on pathways to bring this innovation into the U.S. military and VA hospital systems to enhance patient care.
- Global Interest – Early discussions are underway with international partners, with potential expansion opportunities in 1-2 countries outside the U.S.
Setting Expectations & Seizing Opportunities
Launching a revolutionary medical device requires time and effort to gain early adopters. But here’s why we’re confident in our success:
✅ Zero Direct Competitors – No other device offers what the Turbo® O₂ Cap does.
✅ Strong IP Protection – Backed by 3 issued patents and 4 pending patents.
✅ Built for Repeat Sales – The device is disposable, ensuring ongoing demand from medical providers.
How You Can Help
We’re rapidly expanding our market reach and welcome fresh ideas, connections, and strategic input to accelerate sales growth.
- Do you have contacts in hospitals or healthcare sales teams?
- Do you see unique market opportunities we should explore?
We welcome your insights and collaboration to drive the success of the Turbo® O₂ Cap, shaping the future of medical technology together.
For more information about the Turbo® O₂ Cap and SharpMed, LLC, please contact:
Anthony Escandon
VP of Sales
Email: aescandon@sharpmed.com